litlas
Log inCreate account

Thomas Tursz

Active 1980–2010

67
Papers
22,607
Citations
67
h-index
67
i10-index

Citations

Citations per year for Thomas Tursz1978: 1 citations1982: 5 citations1983: 4 citations1984: 17 citations1985: 15 citations1986: 26 citations1987: 25 citations1988: 34 citations1989: 40 citations1990: 49 citations1991: 81 citations1992: 100 citations1993: 79 citations1994: 81 citations1995: 118 citations1996: 82 citations1997: 81 citations1998: 93 citations1999: 107 citations2000: 123 citations2001: 97 citations2002: 125 citations2003: 108 citations2004: 169 citations2005: 188 citations2006: 219 citations2007: 254 citations2008: 303 citations2009: 268 citations2010: 270 citations2011: 270 citations2012: 295 citations2013: 255 citations2014: 296 citations2015: 296 citations2016: 265 citations2017: 306 citations2018: 280 citations2019: 575 citations2020: 652 citations2021: 616 citations2022: 469 citations2023: 391 citations2024: 443 citations2025: 201 citations2026: 3 citations1979–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,711 citing papers, 26.8% of this breakdownChina: 1,194 citing papers, 11.8% of this breakdownFrance: 749 citing papers, 7.4% of this breakdownUnited Kingdom: 530 citing papers, 5.3% of this breakdownGermany: 514 citing papers, 5.1% of this breakdownItaly: 457 citing papers, 4.5% of this breakdownJapan: 376 citing papers, 3.7% of this breakdownAustralia: 287 citing papers, 2.9% of this breakdownSweden: 283 citing papers, 2.8% of this breakdownNetherlands: 274 citing papers, 2.7% of this breakdownCanada: 236 citing papers, 2.3% of this breakdownSouth Korea: 206 citing papers, 2% of this breakdown
0%26.8%Other 22.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology43%
  • Medicine30.1%
  • Immunology and Microbiology23.2%
  • Engineering1.6%
  • Neuroscience0.5%
  • Materials Science0.4%
  • Other1.2%

Topics

  • Extracellular vesicles in disease9.2%
  • Immunotherapy and Immune Responses7.3%
  • Immune Cell Function and Interaction6.1%
  • MicroRNA in disease regulation5%
  • Cancer Immunotherapy and Biomarkers4.7%
  • RNA Interference and Gene Delivery3.6%
  • Other64.1%

Coauthors

All papers

Open in search
  1. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

    Authors: Lionel Apétoh, François Ghiringhelli, Antoine Tesnière, Michel Obéid, Carla Ortiz, Alfredo Criollo, Grégoire Mignot, Maria Chiara Maiuri, Evelyn Ullrich, Patrick Saulnier, Huan Yang, Sebastián Amigorena, Bernard Ryffel, Franck J. Barrat, Paul Säftig, Françis Lévi, Rosette Lidereau, Catherine Noguès, Jean‐Paul Mira, Agnès Chompret, V. Joulin, Françoise Clavel‐Chapelon, Jean Bourhis, Fabrice André, Suzette Delaloge, Thomas Tursz, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2007 cited by 2,969

  2. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

    Authors: Bernard Escudier, Thierry Dorval, Nathalie Chaput, Fabrice André, Marie-Pierre Caby, Sophie Novault, Caroline Flament, Christophe Leboulaire, Christophe Borg, Sebastián Amigorena, C Boccaccio, Christian Bonnerot, Olivier Dhellin, Mojgan Movassagh, Sophie Piperno, Caroline Robert, Vincent Serra, Nancy Valente, Jean‐Bernard Le Pecq, Alan Spatz, Olivier Lantz, Thomas Tursz, Eric Angevin, Laurence Zitvogel - Journal of Translational Medicine 2005 cited by 1,259

  3. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

    Authors: Joseph Wolfers, Anne Lozier, Graça Raposo, Armelle Régnault, Clotilde Théry, Carole Masurier, Caroline Flament, Stéphanie Pouzieux, Florence Faure, Thomas Tursz, Eric Angevin, Sebastián Amigorena, Laurence Zitvogel - Nature Medicine 2001 cited by 1,615

  4. Malignant effusions and immunogenic tumour-derived exosomes

    Authors: Fabrice André, Noël E.C. Schartz, Mojgan Movassagh, Caroline Flament, Patricia Pautier, Philippe Morice, Christophe Pomel, Catherine Lhommé, Bernard Escudier, Thierry Le Chevalier, Thomas Tursz, Sebastián Amigorena, Graça Raposo, Eric Angevin, Laurence Zitvogel - The Lancet 2002 cited by 940

  5. Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα

    Authors: Sophie Viaud, Magali Terme, Caroline Flament, Julien Taı̈eb, Fabrice André, Sophie Novault, Bernard Escudier, Caroline Robert, Sophie Caillat‐Zucman, Thomas Tursz, Laurence Zitvogel, Nathalie Chaput - PLoS ONE 2009 cited by 436

  6. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

    Authors: François Ghiringhelli, Cédric Menard, Magali Terme, Caroline Flament, Julien Taı̈eb, Nathalie Chaput, Pierre E. Puig, Sophie Novault, Bernard Escudier, Éric Vivier, A. Lecesne, Caroline Robert, Jean‐Yves Blay, Jacky Bernard, Sophie Caillat‐Zucman, António A. Freitas, Thomas Tursz, Orianne Wagner‐Ballon, Claude Capron, William Vainchencker, François Martin, Laurence Zitvogel - The Journal of Experimental Medicine 2005 cited by 919

  7. Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?

    Authors: Sophie Viaud, Clotilde Théry, Stéphanie Ploix, Thomas Tursz, Valérie Lapierre, Olivier Lantz, Laurence Zitvogel, Nathalie Chaput - Cancer Research 2010 cited by 332

  8. Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells

    Authors: Fabrice André, Nathalie Chaput, Noël E.C. Schartz, Caroline Flament, N. Aubert, Jacky Bernard, François A. Lemonnier, Graça Raposo, Bernard Escudier, Di‐Hwei Hsu, Thomas Tursz, Sebastián Amigorena, Eric Angevin, Laurence Zitvogel - The Journal of Immunology 2004 cited by 491

  9. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

    Authors: Lionel Apétoh, François Ghiringhelli, Antoine Tesnière, Alfredo Criollo, Carla Ortiz, Rosette Lidereau, C. Mariette, Nathalie Chaput, Jean‐Paul Mira, Suzette Delaloge, Fabrice André, Thomas Tursz, Guido Kroemer, Laurence Zitvogel - Immunological Reviews 2007 cited by 557

  10. Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade

    Authors: Sophie Viaud, Stéphanie Ploix, Valérie Lapierre, Clotilde Théry, Pierre‐Henri Commère, Dominique Tramalloni, Kévin Gorrichon, Pauline Virault-Rocroy, Thomas Tursz, Olivier Lantz, Laurence Zitvogel, Nathalie Chaput - Journal of Immunotherapy 2010 cited by 195

  11. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo

    Authors: Nadine Fernandez, Anne Lozier, Caroline Flament, Paola Ricciardi‐Castagnoli, Dominique Bellet, Mark Suter, Michel Perricaudet, Thomas Tursz, Eugene Maraskovsky, Laurence Zitvogel - Nature Medicine 1999 cited by 1,044

  12. DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

    Authors: Ken A. Olaussen, Ariane Dunant, Pierre Fouret, Élisabeth Brambilla, Fabrice André, Vincent Haddad, E. Taranchon, Martin Filipits, Robert Pirker, Helmut Popper, Rolf A. Stahel, Laure Sabatier, Jean‐Pierre Pignon, Thomas Tursz, Thierry Le Chevalier, Jean‐Charles Soria - New England Journal of Medicine 2006 cited by 1,728

  13. Exosomes for cancer immunotherapy

    Authors: Fabrice André, Bernard Escudier, Eric Angevin, Thomas Tursz, Laurence Zitvogel - Annals of Oncology 2004 cited by 111

  14. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

    Authors: Sylvie Négrier, Bernard Escudier, Christine Lasset, Jean‐Yves Douillard, J. Savary, Christine Chevreau, Alain Ravaud, A. Mercatello, J Pény, Mireille Mousseau, Thierry Philip, Thomas Tursz - New England Journal of Medicine 1998 cited by 969

  15. Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

    Authors: Véronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, Philippe Dessen, Marguerite Stas, Soledad Alonso, Marie‐Françoise Avril, Pablo L. Ortiz‐Romero, Thomas Robert, Ovidiu Bălăcescu, Alexander M.M. Eggermont, Gilbert Lenoir, Alain Sarasin, Thomas Tursz, Joost J. van den Oord, Alan Spatz - JNCI Journal of the National Cancer Institute 2006 cited by 479

  16. Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection

    Authors: Nathalie Chaput, Noël E.C. Schartz, Fabrice André, Julien Taı̈eb, Sophie Novault, Pierre Bonnaventure, N. Aubert, Jacky Bernard, François A. Lemonnier, Miriam Mérad, Gosse J. Adema, Malcolm Adams, Maria Ferrantini, Alain Carpentier, Bernard Escudier, Thomas Tursz, Eric Angevin, Laurence Zitvogel - The Journal of Immunology 2004 cited by 266

  17. A novel dendritic cell subset involved in tumor immunosurveillance

    Authors: Julien Taı̈eb, Nathalie Chaput, Cédric Menard, Lionel Apétoh, Evelyn Ullrich, Mathieu Bonmort, Marie O. Péquignot, Noëlia Casares, Magali Terme, Caroline Flament, Paule Opolon, Yann Lécluse, Didier Métivier, Elena Tomasello, Éric Vivier, François Ghiringhelli, François Martin, David Klatzmann, Thierry Poynard, Thomas Tursz, Graça Raposo, Hideo Yagita∥, Bernard Ryffel, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2006 cited by 397

  18. Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity

    Authors: Hanne Gahéry‐Ségard, Françoise Farace, Dominique Godfrin, Jésintha Gaston, Renée Lengagne, Thomas Tursz, Pierre Boulanger, Jean‐Gérard Guillet - Journal of Virology 1998 cited by 212

  19. CD77: an antigen of germinal center B cells entering apoptosis

    Authors: Marianne Mangeney, Yolande Richard, Dominique Coulaud, Thomas Tursz, Joëlle Wiels - European Journal of Immunology 1991 cited by 186

  20. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells

    Authors: Corinne Capoulade, Brigitte Bressac–de Paillerets, Isabelle Lefrère, Muriel Ronsin, Jean Feunteun, Thomas Tursz, Joëlle Wiels - Oncogene 1998 cited by 123

  21. Epstein-Barr Virus Gene Expression in Nasopharyngeal Carcinoma

    Authors: Lawrence S. Young, William O. Dawson, D. Clark, H. Rupani, Pierre Busson, Thomas Tursz, A. Johnson, A. B. Rickinson - Journal of General Virology 1988 cited by 471

  22. Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma

    Authors: Robin Fåhræus, Hu Li Fu, Ingemar Ernberg, Jürgen Finke, Martin Rowe, George Klein, Kerstin I. Falk, E Nilsson, Manmohan Yadav, Pierre Busson, Thomas Tursz, Bengt Kallin - International Journal of Cancer 1988 cited by 443

  23. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects

    Authors: Christophe Borg, Magali Terme, Julien Taı̈eb, Cédric Menard, Caroline Flament, Caroline Robert, Koji Maruyama, Hiro Wakasugi, Eric Angevin, Kris Thielemans, Axel Le Cesne, Véronique Chung-Scott, Vladimir Lazar, Isabelle Tchou, Florent Crépineau, François M. Lemoine, Jacky Bernard, Jonhantan A. Fletcher, Ali G. Turhan, Jean‐Yves Blay, Alan Spatz, Jean-François Emile, Michael C. Heinrich, Salaheddine Mécheri, Thomas Tursz, Laurence Zitvogel - Journal of Clinical Investigation 2004 cited by 287

  24. A Glycolipid Antigen Associated with Burkitt Lymphoma Defined by a Monoclonal Antibody

    Authors: Edward Nudelman, Reiji Kannagi, Sen‐itiroh Hakomori, Marilyn Parsons, Marta M. Lipinski, Joëlle Wiels, Marc Fellous, Thomas Tursz - Science 1983 cited by 242